Nomura Holdings’s NanoViricides NNVC Stock Holding History

Nomura Holdings’s Portfolio NNVC Stock Details NNVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-2,573	Closed	-$114K	–	1493
2016 Q1	$114K	Buy	+2,573	New	+$99.9K	﹤0.01%	1372

Other funds holding NNVC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

SCA

STALEY CAPITAL ADVISERS Pittsburgh, Pennsylvania $2.36B AUM 23.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Nomura Holdings's NNVC Position: Q2 2016 in Review

Nomura Holdings sold out of NanoViricides (NNVC) in Q2 2016, closing a stake of 2,573 shares — an estimated $114K sold.

Nomura Holdings first reported a position in NNVC in Q1 2016 and held it in 1 quarter. The position peaked at $114K in Q1 2016. 51 funds tracked by Wall St. Rank hold NNVC as of Q2 2016.

Nomura Holdings reported no remaining NanoViricides position as of Q2 2016 after selling out during the quarter.
Nomura Holdings sold 2,573 NanoViricides shares in Q2 2016, an estimated $114K.
Nomura Holdings first reported a position in NanoViricides in Q1 2016 and held it in 1 quarter.
Nomura Holdings's NanoViricides position peaked at $114K in Q1 2016.
51 funds tracked by Wall St. Rank held NanoViricides as of Q2 2016.

Based on Nomura Holdings's 13F filing for Q2 2016, filed 15 Aug 2016.